Credit Suisse Asset Management (CSAM) is set to launch two new Luxembourg-domiciled funds on May 14.
The global health care fund will concentrate on large to mid-cap companies worldwide which operate in pharmaceuticals, hospital supplies, medical technology, biotechnology and those which provide services to the healthcare industry.
“We have witnessed an increasing appetite among both institutional and private investors for opportunities to invest in this sector, which has historically provided good above average rates of return. Many investors, however, do not have access to the technological and sector expertise to invest knowledgeably and confidently”, said Emil Doerig, who is overseeing the fund at CSAM.
The European convertible bond fund will focus on top-level issuers, with steady earnings within growth sectors. Winifred Robbins, CSAM manager for the fund added: “Convertibles offers investors an opportunity to benefit both from the upside potential of equities, whilst also being able to benefit from some downside protection during periods of market weakness.”
The global health care fund is benchmarked against MSCI Health Care, with the European convertible bond fund set against the UBS Warburg European Convertible Index.
Both funds are available in Austria, Finland, France, Luxembourg, the Netherlands, Norway, Sweden and Switzerland. Registration is pending in Germany, Italy and Spain.
By Madhu Kalia
Royal London has announced that group chief executive Phil Loney has decided to stand down by the end of 2019.
Crashing out of the European Union without a deal could cause a 37% increase in the aggregate buyout deficit for defined benefit (DB) schemes, says Cardano.
Brunel Pension Partnership has launched its authorised contractual scheme (ACS) and first sub-fund managing around £1.6bn of UK equities.
NEST's director of business development Helen Dowsey speaks to James Phillips about communications, sidecar savings, and retirement products.